Age: 73.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19
Symptoms: Neuropathy peripheral, Ophthalmic migraine, Pain, Parosmia, Pyrexia
Clinical narrative: grade 2 LV diastolic dysfunction; Heart pain/pressure; Lung congestion; Vision loss; Shortness of breath; Joint pain and swelling; Aches all over body; Significant weight loss (10% of body weight in four weeks).; impaired vision; Changes in taste and smell; Changes in taste and smell; Cognitive decline; Disoriented; Dizzy; Feeling in nerves like electric shocks; Insomnia; Headache; Light sensitive; Extreme fatigue; Joint pain and swelling; Heart damage as shown by PULS blood test and ECHO test; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 73-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Nov2021 at 12:00 as dose 3 (booster), single (Lot number: fh8030) at the age of 73 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "red (cayenne) pepper" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "allergy" (unspecified if ongoing). Concomitant medication(s) received in two weeks included: HYDROCHLOROTHIAZIDE taken for blood pressure abnormal (It was not high then); WIXELA INHUB taken for hypersensitivity, start date: 2017 (once a day lowest dose Inhaled). The report was not related to a study or programme. Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EL9261, Location of injection: Arm Left, Vaccine Administration Time: 01:00 PM), administration date: 26Jan2021, for COVID-19 immunization, reaction(s): "She had minor face flushing"; BNT162b2 (Dose Number: 2, Batch/Lot No: EN6201, Location of injection: Arm Right, Vaccine Administration Time: 01:15 PM), administration date: 16Feb2021, for Covid-19 Immunization, reaction(s): "Disorientation", "Fatigue", "could not get out of bed for 3 days", "woke up from sleep with fever", "chest pain", "swollen joints". The following information was reported: PAIN (disability) with onset 19Nov2021, outcome "not recovered", described as "Aches all over body"; TASTE DISORDER (disability), PAROSMIA (disability) all with onset 19Nov2021, outcome "not recovered" and all described as "Changes in taste and smell"; COGNITIVE DISORDER (disability) with onset 19Nov2021, outcome "not recovered", described as "Cognitive decline"; DISORIENTATION (disability) with onset 19Nov2021, outcome "recovering", described as "Disoriented"; DIZZINESS (disability) with onset 19Nov2021, outcome "not recovered", described as "Dizzy"; FATIGUE (disability) with onset 19Nov2021, outcome "not recovered", described as "Extreme fatigue"; NERVE INJURY (disability) with onset 19Nov2021, outcome "not recovered", described as "Feeling in nerves like electric shocks"; HEADACHE (disability) with onset 19Nov2021, outcome "not recovered"; CARDIAC DISORDER (disability, life threatening) with onset 19Nov2021, outcome "not recovered", described as "Heart damage as shown by PULS blood test and ECHO test"; ANGINA PECTORIS (disability, medically significant) with onset 19Nov2021, outcome "not recovered", described as "Heart pain/pressure"; INSOMNIA (disability) with onset 19Nov2021, outcome "not recovered"; JOINT SWELLING (disability), ARTHRALGIA (disability) all with onset 19Nov2021, outcome "not recovered" and all described as "Joint pain and swelling"; HYPERSENSITIVITY (disability) with onset 19Nov2021, outcome "not recovered", described as "Light sensitive"; PULMONARY CONGESTION (disability, medically significant) with onset 19Nov2021, outcome "not recovered", described as "Lung congestion"; DYSPNOEA (disability) with onset 19Nov2021, outcome "unknown", described as "Shortness of breath"; WEIGHT DECREASED (disability) with onset 19Nov2021, outcome "not recovered", described as "Significant weight loss (10% of body weight in four weeks)."; BLINDNESS (disability, medically significant) with onset 19Nov2021, outcome "not recovered", described as "Vision loss"; VISUAL IMPAIRMENT (disability) with onset 19Nov2021, outcome "not recovered", described as "impaired vision"; DIASTOLIC DYSFUNCTION (life threatening), outcome "unknown", described as "grade 2 LV diastolic dysfunction". The events "heart damage as shown by puls blood test and echo test", "grade 2 lv diastolic dysfunction", "heart pain/pressure", "lung congestion", "vision loss", "shortness of breath", "joint pain and swelling", "aches all over body", "significant weight loss (10% of body weight in four weeks).", "impaired vision", "changes in taste and smell", "cognitive decline", "disoriented", "dizzy", "feeling in nerves like electric shocks", "insomnia", "headache", "light sensitive" and "extreme fatigue" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood test: (unspecified date) unknown; Echoencephalogram: (unspecified date) unknown; SARS-CoV-2 test: (30Dec2021) Negative, notes: Nasal Swab; (08Mar2022) Negative, notes: Nasal Swab; Ultrasound antenatal screen: (unspecified date) unknown; Weight decreased: (unspecified date) Significant weight loss, notes: 10% of body weight in four weeks. Therapeutic measures were taken as a result of cardiac disorder, diastolic dysfunction, angina pectoris, pulmonary congestion, blindness, dyspnoea, joint swelling, pain, weight decreased, visual impairment, taste disorder, parosmia, cognitive disorder, disorientation, dizziness, nerve injury, insomnia, headache, hypersensitivity, fatigue, arthralgia. Clinical course: NDC number and expiry date: Unknown. The patient was not diagnosed with COVID-19 prior to the vaccination. The patient has been tested for COVID-19 after vaccination. Patient tried to get her doctor to complete the report for 5 months and finally found portal herself. Patient could not get an appointment until Jan2022. Echo conducted last Thursday showed left ventricle diastolic dysfunction.  Grade 2. The rest of symptoms occurred immediately after booster and persisted for 6-7 weeks. They all persist to varying degrees. Medical treatment diagnosis is taking 6 months due to inability to get appointments. Patient received medical attention on 06Jan2022, and it led to long series of testing and trying to bring in a cardiologist and get appropriate test like Echo. Right up until this time, patient is receiving medical assistance for testing and diagnosis, and it is not done yet. Patient would like to know if she risks getting another booster or not. Patient declines to provide LOT/Batch numbers for first, second, and third doses of the vaccine. Patient says she has heart damage and is exhausted and has already provided way more details than she should need to do. Patient says federal law requires that doctors submit a VAERS report for adverse events, which she believed was true until yesterday when found the Pfizer vaccine adverse event reporting portal as an alternate route for reports by patients, that she was glad to find. Patient says she would like to know, is it mandatory for Pfizer to report VAERS statistics, since it is set up and would be a good process if that information sees the light of day or is added to CDC overall information and used with VAERS. Patient is a 75-year-old who was 74 years old when she received the booster dose of the Pfizer Covid-19 vaccine. Patient reports that after the booster dose of the Pfizer Covid-19 vaccine on 19Nov2021 has heart damage, that an echocardiogram was done and has grade 2 LV diastolic dysfunction. Patient reports that she is still not okay and may die of this. Patient reports that the Johnston and Johnston Covid-19 vaccine has been taken off the market due to side effects and the Moderna Covid-19 vaccine has more side effects reported for it than the Pfizer Covid-19 vaccine. AE treatment ongoing testing now, cardiologist retained.